Receptors for proteins modified by advanced glycation endproducts (AGE)--their functional role in atherosclerosis.
about
Telomeres and Telomerase in Cardiovascular DiseasesBiodistribution and elimination study of fluorine-18 labeled Nε-carboxymethyl-lysine following intragastric and intravenous administrationThe maillard reaction in eye diseases.N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status.Advanced glycation end products increase lipids accumulation in macrophages through upregulation of receptor of advanced glycation end products: increasing uptake, esterification and decreasing efflux of cholesterolDietary hyperglycemia, glycemic index and metabolic retinal diseases.Protein oxidative damage in the stratum corneum: Evidence for a link between environmental oxidants and the changing prevalence and nature of atopic dermatitis in Japan.Characterisation of the advanced glycation endproduct receptor complex in the retinal pigment epitheliumLigands of macrophage scavenger receptor induce cytokine expression via differential modulation of protein kinase signaling pathways.Macrophage apoptosis in advanced atherosclerosis.Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products.Pathological roles of advanced glycation end product receptors SR-A and CD36.Cathepsin D is one of the major enzymes involved in intracellular degradation of AGE-modified proteins.Limited accumulation of damaged proteins in l-isoaspartyl (D-aspartyl) O-methyltransferase-deficient mice.Effects of scavenger receptors-1 class A stimulation on macrophage morphology and highly modified advanced glycation end product-protein phagocytosis.Chemotherapeutic-Induced Cardiovascular Dysfunction: Physiological Effects, Early Detection-The Role of Telomerase to Counteract Mitochondrial Defects and Oxidative Stress.
P2860
Q28076220-B434BB1A-00ED-4815-A684-83BA42D872E3Q28487790-BF30C3B6-3A85-4ABC-BC3A-9EF895DD8A0DQ34436018-F2E35D28-E395-446A-A90B-3C5AA31797FCQ37036184-A75F602F-125A-4FDD-B744-85B29391BC43Q37267563-4724440F-B05A-44C6-B5C2-8492AF989D72Q37733102-B0A2ACCD-A703-42BA-9DB5-E94DCFA7682AQ39658037-62BFF570-CCAF-4497-9DCB-657253F31D73Q40477757-B2146F20-1D53-4DCB-912A-7593AF7AA3FBQ40801423-BAAC76E9-0AE4-4330-92E1-83B39F1380F8Q41851126-CDAAAAEA-92F1-45E0-92B2-1AAA19949D6FQ41894332-C5222DCF-B0F2-4276-8020-C609395DAD7DQ42812060-EE1CBF01-10BB-4007-B305-911FB3BE95B5Q43013056-C6BAEEAB-AF0D-4FDF-AECD-ACDC39E1A94CQ43560357-1A8554F1-5460-463F-B582-443ADD7EB634Q52590915-3EC052D2-3359-404C-8DF1-DCA8D64F53BBQ54959206-07328C33-D28E-4C23-BA52-8D6D2AEAC43A
P2860
Receptors for proteins modified by advanced glycation endproducts (AGE)--their functional role in atherosclerosis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Receptors for proteins modifie ...... ional role in atherosclerosis.
@ast
Receptors for proteins modifie ...... ional role in atherosclerosis.
@en
type
label
Receptors for proteins modifie ...... ional role in atherosclerosis.
@ast
Receptors for proteins modifie ...... ional role in atherosclerosis.
@en
prefLabel
Receptors for proteins modifie ...... ional role in atherosclerosis.
@ast
Receptors for proteins modifie ...... ional role in atherosclerosis.
@en
P2093
P1476
Receptors for proteins modifie ...... ional role in atherosclerosis.
@en
P2093
P304
P356
10.1016/S0047-6374(99)00011-1
P577
1999-03-01T00:00:00Z